Jorge Plutzky, M.D. is Director, Preventive Cardiology at Brigham and Women’s Hospital (BWH), which includes the BWH Lipid/Prevention Clinic. Dr. Plutzky is recognized as an expert on preventive cardiology with a focus on how metabolic abnormalities like diabetes, obesity and dyslipidemia impact atherosclerosis. These interests are evident in his NIH-funded basic science laboratory that studies transcriptional mechanisms governing connections between these metabolic issues and atherosclerosis as well as in his translational research and clinical efforts. Clinical cardiovascular work includes novel remote, algorithmic management of cardiovascular risk, cardiologist management of diabetes as well as NIH-funded studies on atherosclerotic risk in settings of HIV and rheumatoid arthritis.

Dr. Plutzky’s broad, interdisciplinary perspective has led to his roles with the Food and Drug Administration’s Endocrine and Metabolism Advisory Committee, the American Diabetes Association and the American Heart Association, where he is the past chair of the AHA’s Diabetes Committee, prior chair of the Sarnoff Cardiovascular Research Foundation’s Scientific Committee, and an elected member of the American Society of Clinical Investigation. Dr. Plutzky’s contributions have also been recognized with the University of Cologne’s Klenck Award, Harvard Medical School’s Tucker Collins Lecture in Vascular Biology, the University of Michigan’s Parke Willis Hurst Visiting Professorship and the Braunwald Teaching Award from BWH Cardiology Fellows.

Dr. Plutzky received his B.A., With Highest Distinction, University of Virginia (Echol’s Scholar) and his M.D. from the University of North Carolina, with distinction for research through an NIH research fellowship. Internal medicine residency and cardiology fellowship were all completed at Brigham and Women’s Hospital/Harvard Medical School, which included a post-doctoral research fellowship at the Massachusetts Institute of Technology.